Treatment with masitinib led to lower blood levels of neurofilament light chain (NfL) and pro-inflammatory signaling ...

The signaling molecule IL-6, involved in inflammation, is associated with increasing frailty in relapsing-remitting MS, a ...

Dr Belinda Kaskow explores the benefits of investigating the early stages of immune dysregulation in MS to enhance prevention ...

"Mono," caused by Epstein-Barr virus, raises the risk of multiple sclerosis, but it's unclear why. A study pinpoints a ...

Integrating a blood-based biomarker assay into clinical workflows can enhance decision-making in patients with multiple ...

Q1 2025 Earnings Conference Call May 9, 2025 10:00 AM ETCompany ParticipantsJustine Koenigsberg - Vice President ...

A study published in Neurotherapeutics dives into the role of the gut microbiome in the pathogenesis and progression of multiple sclerosis (MS), a chronic | Drug Discovery And Development ...

A new treatment option for people with multiple sclerosis (MS) could alleviate resource strains on New Zealand's health system. Medsafe has registered Ocrevus Subcutaneous, a 10-minute injection for ...

CHARLESTON, S.C. (WCSC) - Hundreds of people gathered at James Island County Park to participate in a Walk MS event, fundraising for research and raising awareness about the autoimmune disease ...

In 2018, Blair was diagnosed with multiple sclerosis (MS), a disease that affects the central nervous system. At first, this might sound like bad news. But for Blair, getting the diagnosis was ...

An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.